Molecular Templates, Inc. (MTEM): Price and Financial Metrics


Molecular Templates, Inc. (MTEM)

Today's Latest Price: $9.12 USD

0.28 (3.17%)

Updated Nov 27 1:00pm

Add MTEM to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MTEM Stock Summary

  • Of note is the ratio of Molecular Templates Inc's sales and general administrative expense to its total operating expenses; merely 11.53% of US stocks have a lower such ratio.
  • With a price/sales ratio of 20.5, Molecular Templates Inc has a higher such ratio than 91.79% of stocks in our set.
  • With a year-over-year growth in debt of 103.7%, Molecular Templates Inc's debt growth rate surpasses 88.4% of about US stocks.
  • Stocks that are quantitatively similar to MTEM, based on their financial statements, market capitalization, and price volatility, are KALV, NTLA, CRBP, NXTC, and FIXX.
  • MTEM's SEC filings can be seen here. And to visit Molecular Templates Inc's official web site, go to www.mtem.com.

MTEM Stock Price Chart Interactive Chart >

Price chart for MTEM

MTEM Price/Volume Stats

Current price $9.12 52-week high $19.12
Prev. close $8.84 52-week low $7.51
Day low $8.80 Volume 162,956
Day high $9.19 Avg. volume 357,456
50-day MA $10.20 Dividend yield N/A
200-day MA $13.10 Market Cap 455.67M

Molecular Templates, Inc. (MTEM) Company Bio


Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is based in Austin, Texas.


MTEM Latest News Stream


Event/Time News Detail
Loading, please wait...

MTEM Latest Social Stream


Loading social stream, please wait...

View Full MTEM Social Stream

Latest MTEM News From Around the Web

Below are the latest news stories about Molecular Templates Inc that investors may wish to consider to help them evaluate MTEM as an investment opportunity.

Molecular Templates (MTEM) Investor Presentation - Slideshow

The following slide deck was published by Molecular Templates, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 21, 2020

Molecular Templates raises $43M

Molecular Templates (MTEM) has raised ~$43M through its At-the-Market facility, with participation from Consonance Capital Management.The Company sold ~3.6M shares at $12, the market price at the time of sale. The additional funds raised through the ATM will be used to advance the Company’s pipeline, as well as for working...

Seeking Alpha | July 20, 2020

Molecular Templates, Inc. Raises $43 Million in Gross Proceeds Through Its At-the-Market Facility

AUSTIN, Texas, July 20, 2020 -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on.

Yahoo | July 20, 2020

Is Molecular Templates, Inc. (MTEM) A Good Stock To Buy?

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]

Yahoo | June 24, 2020

Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2020 Highlight Evolution of ETB Platform

Update Provided Phase I Study of MT-5111 in HER2-positive Cancers Conference Call and Webcast to Discuss AACR Posters on June 25th at 10:30am Eastern Time AUSTIN, Texas, June.

Yahoo | June 22, 2020

Read More 'MTEM' Stories Here

MTEM Price Returns

1-mo -2.77%
3-mo -19.65%
6-mo -41.24%
1-year -18.06%
3-year 13.43%
5-year -77.41%
YTD -34.79%
2019 246.16%
2018 -59.68%
2017 107.02%
2016 -8.33%
2015 -84.91%

Continue Researching MTEM

Want to see what other sources are saying about Molecular Templates Inc's financials and stock price? Try the links below:

Molecular Templates Inc (MTEM) Stock Price | Nasdaq
Molecular Templates Inc (MTEM) Stock Quote, History and News - Yahoo Finance
Molecular Templates Inc (MTEM) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8663 seconds.